Transcatheter aortic valve implantation: Results of a new therapeutic option for high surgical risk aortic stenosis;Implantação percutânea de próteses valvulares aórticas: Resultados de uma nova opção terapêutica na estenose aórtica com alto risco cirúrgico

Revista Portuguesa de Cardiologia

Volumn 31, Issue 2, 2012, Pages 143-149

  Salinas, Pablo ^a   Moreno, Raul ^a   Calvo, Luis ^a   Dobarro, David ^a   Jiménez Valero, Santiago ^a   Sánchez Recalde, Angel ^a   Gaçeote, Guillermo ^a   Riera, Luis ^a   González Montalvo, Juan Ignacio ^a   Plaza, Ignacio ^b   Mariscal, Francisco ^a   Gonzalez Davia, Rosa ^c   López, Teresa ^a   Moreno, Mar ^a   Alvarez, Arturo ^a   Cuesta, Emilio ^a   Garzon, Gonzalo ^a   Filgueiras, David ^a   Moreno Gomez, Isidro ^a   Mesa, Jose María ^a   López Sendon, Jose Luis ^a   more..

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^b HOSPITAL UNIVERSITARIO INFANTA SOFÍA   (Spain)

^c HOSPITAL INFANTA CRISTINA   (Spain)

Author keywords

Aortic valve replacement; Aortic valve stenosis; Heart valve prosthesis; Non coronary intervention; Transcatheter aortic valve implantation

Indexed keywords

AGED; AORTA STENOSIS; APPLICATION SITE BLEEDING; ARTICLE; ARTIFICIAL HEART PACEMAKER; DISEASE SEVERITY; FOLLOW UP; HEALTH PROGRAM; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; PROSPECTIVE STUDY; SURGICAL PATIENT; SURGICAL RISK; TRANSCATHETER AORTIC VALVE IMPLANTATION; TRANSFUSION;

EID: 84858224787     PISSN: 08702551     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.repc.2011.12.008     Document Type: Article

References (21)

1. Lung B, Baron G, Butchart EG, et al. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur Heart J. 2003;24:1231-43. (Pubitemid 36834640)
2. Nkomo VT, Gardin JM, Skelton TN, et al. Burden of valvular heart diseases: a population-based study. Lancet. 2006;368:1005-11. (Pubitemid 44353666)
3. Kvidal P, Bergstrom R, Horte LG, et al. Observed and relative survival after aortic valve replacement. J Am Coll Cardiol. 2000;35:747-56. (Pubitemid 30167033)
4. Vahanian A, Baumgartner H, Bax J, et al. Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J. 2007;28:230-68. (Pubitemid 46276943)
5. lung B, Cachier A, Baron G, et al. Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery? Eur Heart J. 2005;26:2714-20.
6. Salinas P, Moreno R, Lopez-Sendon JL. Transcatheter aortic valve implantation: Current status and future perspectives. World J Cardiol. 2011;3(6):177-85.
7. Cribier A, Eltchaninoff H, Bash A, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation. 2002;106:3006-8. (Pubitemid 35440280)
8. Moreno R, Calvo L, Filgueiras D, et al. [Percutaneous implantation of aortic valve prosthesis in patients with symptomatic severe aortic stenosis rejected for surgical valve replacement] (artigo em espanhol). Rev Esp Cardiol. 2008;61:1215-9.
9. Dobarro D, Moreno R, Filgueiras D, et al. [Implantation of aortic valvular prosthesis via transfemoral catheter. Evaluation of candidates undergoing the procedure] (artigo em espanhol). Med Clin (Barc). 2009;133:414-21.
10. Roques F, Michel P, Goldstone AR, et al. The logistic EuroSCORE. Eur Heart J. 2003;24:881-2.
11. Edwards FH, Grover FL, Shroyer AL, et al. The Society of Thoracic Surgeons National Cardiac Surgery Database: current risk assessment. Ann Thorac Surg. 1997;63:903-8. (Pubitemid 27128737)
12. Moreno R, Calvo L, Garcia E, et al. Severe septal hypertrophy: is it necessarily a contraindication for the transcatheter implantation of an Edwards-Sapien prosthesis? Rev Esp Cardiol. 2010;63:241-2.
13. Webb JG, Chandavimol M, Thompson CR, et al. Percutaneous aortic valve implantation retrograde from the femoral artery. Circulation. 2006;113:842-50.
14. Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363:1597-607.
15. Thomas M, Schymik G, Walther T, et al. Thirty-day results of the SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) Registry: A European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation. 2010;122:62-9.
16. Moreno R, Dobarro D, Lopez de Sa E, et al. Cause of complete atrioventricular block after percutaneous aortic valve implantation: insights from a necropsy study. Circulation. 2009;120:e29-30.
17. Lindroos M, Kupari M, Heikkila J, et al. Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample. J Am Coll Cardiol. 1993;21:1220-5. (Pubitemid 23106200)
18. Tchetche D, Dumonteil N, Sauguet A, et al. Thirty-day outcome and vascular complications after transarterial aortic valve implantation using both Edwards Sapien and Medtronic Core-Valve bioprostheses in a mixed population. Eurointervention. 2010;5:659-65.
19. Thomas M. One-year results from the SOURCE registry. Em: 2010 E, ed. Paris, France; 2010.
20. Gomez Rubin De Celix MC, Moreno R, Dobarro D, et al. Severe aortic stenosis in a critical condition. Med Intensive. 2010 Mar 9 [Epub ahead of print].
21. Salinas P, Moreno R, Lopez-Sendón JL. Transcatheter aortic valve implantation: Current status and future perspectives. World J Cardiol. 2011;3:177-85.